Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
Public ClinicalTrials.gov record NCT00254202. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Iloperidone in Schizophrenic Patients in Acute Exacerbation Followed by a Long-term Treatment Phase.
Study identification
- NCT ID
- NCT00254202
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Vanda Pharmaceuticals
- Industry
- Enrollment
- 593 participants
Conditions and interventions
Conditions
Interventions
- Iloperidone Drug
- Ziprasidone Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 17, 2005
- Primary completion
- Sep 25, 2006
- Completion
- Mar 20, 2007
- Last update posted
- Dec 12, 2024
2005 – 2007
United States locations
- U.S. sites
- 33
- U.S. states
- 14
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanda Investigational Site | Little Rock | Arkansas | 72211 | — |
| Vanda Investigational Site | Anaheim | California | 92805 | — |
| Vanda Investigational Site | Cerritos | California | 90703 | — |
| Vanda Investigational Site | Garden Grove | California | 92845 | — |
| Vanda Investigational Site | Glendale | California | 91206 | — |
| Vanda Investigational Site | Los Angeles | California | 90048 | — |
| Vanda Investigational Site | National City | California | 91950 | — |
| Vanda Investigational Site | Oceanside | California | 92056 | — |
| Vanda Investigational Site | Paramount | California | 90723 | — |
| Vanda Investigational Site | Pico Rivera | California | 90660 | — |
| Vanda Investigational Site | San Diego | California | 92123 | — |
| Vanda Investigational Site | San Diego | California | 92126 | — |
| Vanda Investigational Site | San Diego | California | 92161 | — |
| Vanda Investigational Site | Santa Ana | California | 92705 | — |
| Vanda Investigational Site | Upland | California | 91786 | — |
| Vanda Investigational Site | Bradenton | Florida | 34208 | — |
| Vanda Investigational Site | Fort Lauderdale | Florida | 33308 | — |
| Vanda Investigational Site | Maitland | Florida | 32751 | — |
| Vanda Investigational Site | Atlanta | Georgia | 30308 | — |
| Vanda Investigational Site | Augusta | Georgia | 30912 | — |
| Vanda Investigational Site | Hoffman Estates | Illinois | 60194 | — |
| Vanda Investigational Site | Lake Charles | Louisiana | 70601 | — |
| Vanda Investigational Site | Rockville | Maryland | 20850 | — |
| Vanda Investigational Site | Saint Charles | Missouri | 63301 | — |
| Vanda Investigational Site | St Louis | Missouri | 63118 | — |
| Vanda Investigational Site | Clementon | New Jersey | 08021 | — |
| Vanda Investigational Site | Brooklyn | New York | 11203 | — |
| Vanda Investigational Site | Cincinnati | Ohio | 45267 | — |
| Vanda Investigational Site | Philadelphia | Pennsylvania | 19131 | — |
| Vanda Investigational Site | Austin | Texas | 78756 | — |
| Vanda Investigational Site | Houston | Texas | 77057 | — |
| Vanda Investigational Site | Irving | Texas | 75062 | — |
| Vanda Investigational Site | Richmond | Virginia | 23229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00254202, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 12, 2024 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00254202 live on ClinicalTrials.gov.